| Large-scale plasma proteomic analysis identifies proteins and pathways associated with dementia risk KA Walker, J Chen, J Zhang, M Fornage, Y Yang, L Zhou, ME Grams, ... Nature Aging 1 (5), 473-489, 2021 | 118 | 2021 |
| Proteomics analysis of plasma from middle-aged adults identifies protein markers of dementia risk in later life KA Walker, J Chen, L Shi, Y Yang, M Fornage, L Zhou, P Schlosser, ... Science translational medicine 15 (705), eadf5681, 2023 | 49 | 2023 |
| Proteins associated with risk of kidney function decline in the general population ME Grams, A Surapaneni, J Chen, L Zhou, Z Yu, D Dutta, PA Welling, ... Journal of the American Society of Nephrology 32 (9), 2291-2302, 2021 | 42 | 2021 |
| Polygenic risk scores for kidney function and their associations with circulating proteome, and incident kidney diseases Z Yu, J Jin, A Tin, A Köttgen, B Yu, J Chen, A Surapaneni, L Zhou, ... Journal of the American Society of Nephrology 32 (12), 3161-3173, 2021 | 41 | 2021 |
| Serum albumin and risks of hospitalization and death: Findings from the Atherosclerosis Risk in Communities study CM Shannon, SH Ballew, N Daya, L Zhou, AR Chang, Y Sang, J Coresh, ... Journal of the American Geriatrics Society 69 (10), 2865-2876, 2021 | 30 | 2021 |
| Consequences of PCA graphs, SNP codings, and PCA variants for elucidating population structure HG Gauch Jr, S Qian, HP Piepho, L Zhou, R Chen PloS one 14 (6), e0218306, 2019 | 30 | 2019 |
| Metabolite profiling of CKD progression in the chronic renal insufficiency cohort study D Wen, Z Zheng, A Surapaneni, B Yu, L Zhou, W Zhou, D Xie, H Shou, ... JCI insight 7 (20), 2022 | 28 | 2022 |
| Identification of 969 protein quantitative trait loci in an African American population with kidney disease attributed to hypertension A Surapaneni, P Schlosser, L Zhou, C Liu, N Chatterjee, DE Arking, ... Kidney international 102 (5), 1167-1177, 2022 | 19 | 2022 |
| Serum metabolites and kidney outcomes: The atherosclerosis risk in communities study L Bernard, L Zhou, A Surapaneni, J Chen, CM Rebholz, J Coresh, B Yu, ... Kidney Medicine 4 (9), 100522, 2022 | 13 | 2022 |
| Trans-ethnic genome-wide association study of blood metabolites in the Chronic Renal Insufficiency Cohort (CRIC) study EP Rhee, A Surapaneni, Z Zheng, L Zhou, D Dutta, DE Arking, J Zhang, ... Kidney international 101 (4), 814-823, 2022 | 13 | 2022 |
| Spatially coordinated heterochromatinization of long synaptic genes in fragile X syndrome T Malachowski, KR Chandradoss, R Boya, L Zhou, AL Cook, C Su, ... Cell 186 (26), 5840-5858. e36, 2023 | 12 | 2023 |
| A novel creatinine muscle index based on creatinine filtration: associations with frailty and mortality SH Ballew, L Zhou, A Surapaneni, ME Grams, BG Windham, E Selvin, ... Journal of the American Society of Nephrology 34 (3), 495-504, 2023 | 10 | 2023 |
| Integrated proteomic and metabolomic modules identified as biomarkers of mortality in the Atherosclerosis Risk in Communities study and the African American Study of Kidney … L Zhou, A Surapaneni, EP Rhee, B Yu, E Boerwinkle, J Coresh, ... Human genomics 16 (1), 53, 2022 | 8 | 2022 |
| Testican-2 is associated with reduced risk of incident ESKD D Wen, L Zhou, Z Zheng, A Surapaneni, CM Ballantyne, RC Hoogeveen, ... Journal of the American Society of Nephrology 34 (1), 122-131, 2023 | 7 | 2023 |
| Alterations in the circulating proteome associated with albuminuria E Kiernan, A Surapaneni, L Zhou, P Schlosser, KA Walker, EP Rhee, ... Journal of the American Society of Nephrology 34 (6), 1078-1089, 2023 | 5 | 2023 |
| Integrated Proteomic and Metabolomic Modules associated with Risk of Kidney Disease Progression P Schlosser, AL Surapaneni, O Borisov, IM Schmidt, L Zhou, A Anderson, ... Journal of the American Society of Nephrology, 10.1681, 2024 | 3 | 2024 |
| Midlife proteome‐wide analysis identifies plasma biomarkers for 25‐year dementia risk linked to diverse pathophysiology KA Walker, J Chen, L Shi, Y Yang, M Fornage, L Zhou, P Schlosser, ... Alzheimer's & Dementia 18, e062935, 2022 | 1 | 2022 |
| Polygenic risk scores for kidney function to the circulating proteome, and incident kidney diseases: the atherosclerosis risk in communities study Z Yu, J Jin, A Tin, A Köttgen, B Yu, J Chen, A Surapaneni, L Zhou, ... bioRxiv, 2020.09. 05.284265, 2020 | 1 | 2020 |
| Association Between Serum Metabolites and Adverse Renal Outcomes: The Atherosclerosis Risk in Communities (ARIC) Study: PO2250 L Bernard, L Zhou, AL Surapaneni, J Chen, C Rebholz, B Yu, ... Journal of the American Society of Nephrology 32 (10S), 688, 2021 | | 2021 |
| Methodological Considerations for Clustering Omic Data: A Case Study Using Metabolite Data in the African American Study of Kidney Disease and Hypertension (AASK) L Zhou Johns Hopkins University, 2020 | | 2020 |
